Singapore’s Anomaly Bio raises US$2.6M to turn microbes into micro-factories for resilient ingredient supply chains

Singapore’s Anomaly Bio raises US$2.6M to turn microbes into micro-factories for resilient ingredient supply chains

Singapore’s Anomaly Bio raises US$2.6M to turn microbes into micro-factories for resilient ingredient supply chains

DATE

{ SCROLL }
{ SCROLL }
{ SCROLL }

Anomaly develops functional ingredients using advanced fermentation.


We engineer microbes into micro-factories that transform simple sugars into functional ingredients for nutrition, crop protection, and personal care.

By decoupling production from biological and environmental constraints, we’re replacing fragile ingredient supply chains with scalable, on-demand, and globally resilient biomanufacturing.


INTRO
INTRO

Anomaly develops functional ingredients using advanced fermentation.


We engineer microbes into micro-factories that transform simple sugars into functional ingredients for nutrition, crop protection, and personal care.

By decoupling production from biological and environmental constraints, we’re replacing fragile ingredient supply chains with scalable, on-demand, and globally resilient biomanufacturing.